Enhancement of immunocompetence in tuberculosis by DNA vaccination

Vaccine

Volumn 18, Issue 16, 2000, Pages 1712-1716

  Lowrie, Douglas B ^a   Silva, Celio L ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DNA vaccine; Immunotherapy; Tuberculosis

Indexed keywords

DNA VACCINE; GAMMA INTERFERON;

ADOPTIVE TRANSFER; CYTOKINE PRODUCTION; HUMAN; IMMUNOCOMPETENCE; LYMPHOCYTE CLONE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; VACCINATION;

EID: 0033962642     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00512-5     Document Type: Article

References (24)

1. Kochi A. Global challenge of tuberculosis. Lancet. 344:1994;608-609.
2. Hong Kong Chest Service, British Medical Research Council. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Tubercle. 63:1982;89-98.
3. Mitchison D.A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 66:1985;219-225.
4. Smith P.G., Moss A.R. Epidemiology of tuberculosis. Bloom B.R. Tuberculosis: pathogenesis, protection and control. 1994;47-59 American Society for Microbiology, Washington DC.
5. Kenyon T.A., Mwasekaga M.J., Huebner R., Rumisha D., Binkin N., Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int. J. Tuberc. Lung. Dis. 3:1999;4-11.
6. Young D.B., Duncan K. Prospects for new interventions in the treatment and prevention of mycobacterial disease. Annu. Rev. Microbiol. 49:1995;641-673.
7. Lowrie D.B., Tascon R.E., Colston M.J., Silva C.L. Towards a DNA vaccine against tuberculosis. Vaccine. 12:1994;1537-1540.
8. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B. Vaccination against tuberculosis by DNA injection. Nature Medicine. 2:1996;888-892.
9. Lowrie D.B., Silva C.L., Colston M.J., Ragno S., Tascon R.E. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine. 15:1997;834-838.
10. Zhu X.J., Venkataprasad N., Thangaraj H.S., et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:1997;5921-5926.
11. Lozes E., Huygen K., Content J., et al. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine. 15:1997;830-833.
12. Baldwin S.L., Dsouza C., Roberts A.D., et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:1998;2951-2959.
13. Bonato V.L.D., Lima V.M.F., Tascon R.E., Lowrie D.B., Silva C.L. Identification and characterization of protective T cells in hsp65 DNA vaccinated and Mycobacterium tuberculosis infected mice. Infect. Immun. 66:1998;169-175.
14. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., Orme H.I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:1993;2243-2247.
15. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:1993;2249-2254.
16. Warwick Davies J., Lowrie D.B., Cole P.J. Growth hormone activation of human monocytes for superoxide production but not tumor necrosis factor production, cell adherence, or action against Mycobacterium tuberculosis. Infect. Immun. 63:1995;4312-4316.
17. Stenger S., Hanson D.A., Teitelbaum R., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 282:1998;121-125.
18. Oddo M., Renno T., Attinger A., Bakker T., MacDonald H.R., Meylan P.R.A. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160:1998;5448-5454.
19. Raz E., Tighe H., Sato Y., et al. Preferential induction of a Th-1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:1996;5141-5145.
20. Lai W.C., Pakes S.P., Ren K., Lu Y.S., Bennett M. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J. Immunol. 158:1997;2513-2516.
21. Johnston S.A., Barry M.A. Genetic to genomic vaccination. Vaccine. 15:1997;808-809.
22. Silva C.L., Silva M.F., Pietro R.C.L.R., Lowrie D.B. Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65. Infect. Immun. 64:1996;2400-2407.
23. Rees R.J.W., Hart P.D.A. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. Br. J. Exp. Pathol. 42:1961;83-88.
24. McCune R.M., Feldmann F.M., McDermott W. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J. Exp. Med. 123:1996;469-486.